Moody National Bank Trust Division’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-3,565
Closed -$224K – 506
2026
Q1
$224K Sell
3,565
-275
-7% -$22K 0.02% 468
2025
Q4
$366K Buy
3,840
+431
+13% +$42.3K 0.04% 383
2025
Q3
$333K Sell
3,409
-77
-2% -$7.97K 0.03% 397
2025
Q2
$374K Sell
3,486
-270
-7% -$27.3K 0.03% 376
2025
Q1
$379K Buy
3,756
+970
+35% +$97.7K 0.04% 372
2024
Q4
$249K Buy
+2,786
New +$245K 0.03% 432
2023
Q4
– Sell
-15,806
Closed -$835K – 515
2023
Q3
$835K Buy
15,806
+865
+6% +$45.4K 0.05% 261
2023
Q2
$808K Buy
14,941
+76
+0.5% +$3.97K 0.06% 265
2023
Q1
$744K Hold
14,865
– – 0.06% 259
2022
Q4
$688K Sell
14,865
-546
-4% -$23.6K 0.06% 267
2022
Q3
$597K Buy
15,411
+821
+6% +$32.9K 0.06% 285
2022
Q2
$544K Buy
+14,590
New +$594K 0.06% 268
2019
Q2
– Sell
-4,280
Closed -$164K – 448
2019
Q1
$164K Buy
4,280
+528
+14% +$20.2K ﹤0.01% 348
2018
Q4
$133K Buy
3,752
+952
+34% +$34.5K ﹤0.01% 343
2018
Q3
$108K Buy
+2,800
New +$97.8K ﹤0.01% 342

Other funds holding BSX

Moody National Bank Trust Division's BSX Position: Q2 2026 in Review

Moody National Bank Trust Division sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,565 shares — an estimated $224K sold.

Moody National Bank Trust Division first reported a position in BSX in Q3 2018 and held it in 15 quarters. The position peaked at $835K in Q3 2023. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Moody National Bank Trust Division reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Moody National Bank Trust Division sold 3,565 Boston Scientific shares in Q2 2026, an estimated $224K.
  • Moody National Bank Trust Division first reported a position in Boston Scientific in Q3 2018 and held it in 15 quarters.
  • Moody National Bank Trust Division's Boston Scientific position peaked at $835K in Q3 2023.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Moody National Bank Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.